Winning the “Facility of the Year” - Award with an Indian Plant
Sanjit Singh Lamba ()
Additional contact information
Sanjit Singh Lamba: Eisai Pharmatechnology & Mfg. Pvt. Ltd
Chapter Chapter 14 in Leading Pharmaceutical Operational Excellence, 2013, pp 209-226 from Springer
Abstract:
Abstract The Indian economy has undergone several structural changes in the last decades. Beginning with the 1950s, India faced excessive regulation that characterized its industrial development policy for the next four decades. These regulations, set up to govern manufacturing capacity, products, technology etc. had the objective to prevent the developing and capital-scarce economy from costly over capacity. With the opening of India’s economy in the late 1980s inflows of knowledge, foreign technology, and capital has started. Local manufacturers expanded their production and the country became a center of interest for foreign competitors. Moreover, a lack of sufficient import regulations evoked the structural change of the Indian economy. In 1991, India introduced a new set of reforms that substantially reshaped the competitive environment for both domestic and foreign companies. Due to the abolition of India’s license regime, protectionism and control measures came to an end and brought the manufacturing sector at a critical juncture (Dangayachy and Deshmukh 2001). However, although the perception of manufacturing in India as a support activity for marketing and finance rather than the vital value creation of a company is gradually changing, today’s manufacturing still lacks attention of senior management (Chandra and Sastry 1998). Therefore, it’s no wonder, that most companies in India are still far from practices summarized under the umbrella of world class manufacturing (Dangayachy and Deshmukh 2001). Meanwhile, international competitors improve their manufacturing functions continuously, market new products in the country, and thus increase the flexibility and responsiveness of the entire Indian manufacturing sector. As such, the domestic Indian economy experiences rising competition from both multinationals entering the market and from imported goods. This new competition is characterized by the simultaneous combination of a wider range of products – mostly coming with higher performance, reduced cost, improved quality, and better services (Chandra and Sastry 1998; Dangayachy and Deshmukh 2001).
Keywords: Total Dissolve Solid; Drug Substance; Active Pharmaceutical Ingredient; Shop Floor; Active Pharmaceutical Ingredient (search for similar items in EconPapers)
Date: 2013
References: Add references at CitEc
Citations:
There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-642-35161-7_14
Ordering information: This item can be ordered from
http://www.springer.com/9783642351617
DOI: 10.1007/978-3-642-35161-7_14
Access Statistics for this chapter
More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().